Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

News

      FDA clears AstraZeneca’s Covid antibody treatment for immunocompromised

      FDA Approvals
      The FDA authorized the first injectable monoclonal antibody cocktail for long-term prevention of Covid-19 among people with weakened immune systems before they have been...

      Aerogen and CanSinoBIO agree on landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery

      News
      Aerogen® (Galway, Ireland) and CanSinoBIO have announced a development and commercial supply partnership for the inhaled delivery of CanSinoBIO’s Recombinant Novel Coronavirus Vaccine Convidecia™...

      DoKaSch Temperature Solutions strengthens presence in Japan

      News
      DoKaSch Temperature Solutions continues to expand its business in Asia. With the dedicated subsidiary DoKaSch Temperature Solutions K.K. in Tokyo and a new service...

      Concept Life Sciences celebrates GMP accreditation

      News
      Concept Life Sciences (CLS), a Malvern Panalytical brand, announced that it has received certification of compliance with Good Manufacturing Practice (GMP) for the production...

      McSAF and Novasep announce their successful collaboration to produce a next-generation Antibody-Drug Conjugate

      Middle East and South Asia
      Novasep, a leading supplier of services and technologies for the life sciences industry, and McSAF, a French biotech based in Tours, specialized in bioconjugation...

      UPS healthcare continues expansion of capabilities throughout global supply chain

      News
      UPS Healthcare announced a new set of facilities and continued round of global expansion designed to bring unprecedented capabilities to global healthcare logistics customers. One...

      Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19

      Middle East and South Asia
      Pfizer Inc. announced an agreement with the U.S. government to supply 10 million treatment courses of its investigational COVID-19 oral antiviral candidate, PAXLOVID™ (PF-07321332;...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.